Details for New Drug Application (NDA): 020068
✉ Email this page to a colleague
The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the foscarnet sodium profile page.
Summary for 020068
Tradename: | FOSCAVIR |
Applicant: | Clinigen Hlthcare |
Ingredient: | foscarnet sodium |
Patents: | 0 |
Pharmacology for NDA: 020068
Mechanism of Action | Chelating Activity DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 020068
Suppliers and Packaging for NDA: 020068
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068 | NDA | Clinigen Limited | 76310-024 | 76310-024-01 | 10 CARTON in 1 CARTON (76310-024-01) / 1 BOTTLE in 1 CARTON (76310-024-11) / 250 mL in 1 BOTTLE |
FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068 | NDA | Clinigen Limited | 76310-024 | 76310-024-25 | 10 CARTON in 1 CARTON (76310-024-25) / 1 BOTTLE in 1 CARTON (76310-024-15) / 250 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2.4GM/100ML | ||||
Approval Date: | Sep 27, 1991 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 020068
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | ⤷ Subscribe | ⤷ Subscribe |
Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | ⤷ Subscribe | ⤷ Subscribe |
Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | ⤷ Subscribe | ⤷ Subscribe |
Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription